Serina Therapeutics, Inc. (SER): debt financing — AgeX draws $500K under secured convertible note with Juvenescence; due Feb 14, 2024

Serina Therapeutics, Inc.

Drew $500,000 on Jan 3, 2024 from Amended and Restated Secured Convertible Promissory Note.
Lender is Juvenescence Limited; repayment date set as February 14, 2024.
Other terms incorporated by reference from Nov 14, 2023 Form 10-Q.
Total outstanding under the note not disclosed in this filing.

item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Serina Therapeutics, Inc. incurred convertible notes of $500,000 with Juvenescence Limited maturing February 14, 2024.

Instrument: convertible notes
Principal: $500,000
Counterparty: Juvenescence Limited
Maturity: February 14, 2024
Event: incurrence

Exact text from the filing

On January 3, 2024, AgeX drew $500,000 of its credit available under the Amended and Restated Secured Convertible Promissory Note, as amended, (“Secured Note”) with Juvenescence Limited (“Juvenescence”).

View on SEC.gov

Browse all debt financings →

Serina Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-001398

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.